Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Progress and deadlock in German health reforms

This article was originally published in Clinica

Executive Summary

The German coalition government has made progress in one area of the health reforms while talks have broken down in another. The government pushed through its emergency cost-cutting proposals in the Bundestag (lower house) late last month. It is expected that the bill will be passed in September. The government claims that the proposed cost-cutting measures will result in savings of some DM 7,000 million ($4,700 million), which will enable it to cut the average healthcare insurance contribution rate by 0.4%.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT088450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel